Biofusion: still finding its way.

Investors Chronicle - magazine and web content, October, 2007

Biofusion's full-year results showed that it needs to find ways to exit investments sooner rather than later Richard Hemming

At Biofusion's full-year results, chief executive David Baynes trumpeted the company's partnership with Cardiff University and its successful exit from three investments.

But the bottom line for investors is a bigger full-year loss due to higher operating costs and the consolidation of losses from its investment companies. Biofusion has investments in 24 research businesses and aims to commercialise university-generated intellectual property.

Mr Baynes says that Biofusion's cash burn - net cash outflow was GBP2.3m prior to financing - means that the pressure is on for meaningful exits from its investments. But in the...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here